Bacteriophages for Protection from Ultraviolet Irradiation
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsMaryam HAJFATHALIAN, Paul L. BOLLYKY, Michael J. KRATOCHVIL
Life of this patent
Estimating the term…
Abstract
Provided herein are ultraviolet light blocking compositions composed of an active agent containing a phage, phage particle, or other functional component thereof, or another viral particle, or other functional component thereof, in addition to one or more secondary agents useful for application to skin, in industrial or domestic settings, or in agriculture.
Claims35
An ultraviolet light blocking composition comprising an active agent and a secondary agent, wherein the active agent comprises a bacteriophage, a viral particle, or a phage-derived nanoparticle.
(canceled)
6-9. (canceled)
13-17. (canceled)
A method to reduce or eliminate ultraviolet light impact on a mammal's skin surface exposed to ultraviolet light comprising coating the mammal's skin surface with a composition comprising an active agent and a secondary agent, the active agent is a bacteriophage, a viral particle, or a phage-derived nanoparticle.
(canceled)
(canceled)
(canceled)
27-36. (canceled)
38-46. (canceled)
48-51. (canceled)
A method to manufacture a composition for reducing or eliminating ultraviolet light impact, the method comprises combining an active agent, the active agent being bacteriophage, a viral particle, or a phage-derived nanoparticle, with a secondary agent and/or other agents.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
62-67. (canceled)
Dependencies are inferred from the claim text.